Potentiation of in vitro and in vivoantitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cellsMaggie J. Rathos(Piramal (India)), Kalpana Joshi(Piramal (India))BMC CancerJanuary 23, 201310.1186/1471-2407-13-29Cited by 41SaveCiteExport RISWatch citationsRelated PapersP276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines|Molecular Cancer|2012|41